Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.43B |
| 3 |
Boeing
BA
|
+$283M |
| 4 |
CrowdStrike
CRWD
|
+$251M |
| 5 |
Coinbase
COIN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$845M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$837M |
| 3 |
Broadcom
AVGO
|
+$691M |
| 4 |
NVIDIA
NVDA
|
+$662M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$660M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.75% |
| 2 | Technology | 1.85% |
| 3 | Consumer Discretionary | 1.02% |
| 4 | Financials | 0.76% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10726
PUT
Rockwell Medical
RMTI
$32.9M
| $145K | ﹤0.01% |
3,640
+610
| +20% | +$16.4K |
|
|
MXE
10727
Mexico Equity and Income Fund
MXE
$59M
| $144K | ﹤0.01% |
+15,756
| New | +$147K |
|
10728
CALL
Fossil Group
FOSL
$316M
| $144K | ﹤0.01% |
123,200
+79,000
| +179% | +$92.7K |
|
10729
PUT
Atomera
ATOM
$164M
| $144K | ﹤0.01% |
54,800
+3,000
| +6% | +$9.35K |
|
|
10730
PUT
Fossil Group
FOSL
$316M
| $144K | ﹤0.01% |
+123,100
| New | +$144K |
|
|
CCRN
10731
DELISTED
Cross Country Healthcare
CCRN
| $144K | ﹤0.01% |
10,698
-43,892
| -80% | -$647K |
|
10732
Smartbird Inc
BIRD
$30M
| $144K | ﹤0.01% |
12,176
-18,592
| -60% | -$235K |
|
|
BHR
10733
PUT
Braemar Hotels & Resorts
BHR
$139M
| $143K | ﹤0.01% |
46,400
-20,200
| -30% | -$63.4K |
|
10734
Spruce Power Holding Corp
SPRU
$36M
| $143K | ﹤0.01% |
50,468
+19,107
| +61% | +$58.6K |
|
|
VTYX
10735
DELISTED
Ventyx Biosciences
VTYX
| $143K | ﹤0.01% |
65,737
+34,302
| +109% | +$78.9K |
|
10736
CALL
ProShares Short S&P500
SH
$826M
| $143K | ﹤0.01% |
3,300
-2,750
| -45% | -$125K |
|
10737
PUT
Akebia Therapeutics
AKBA
$243M
| $143K | ﹤0.01% |
108,200
-50,100
| -32% | -$66.9K |
|
10738
CALL
Gaia
GAIA
$39.4M
| $143K | ﹤0.01% |
29,300
-12,300
| -30% | -$57.4K |
|
10739
WhiteHorse Finance
WHF
$152M
| $143K | ﹤0.01% |
+12,321
| New | +$147K |
|
|
KALV
10740
PUT
DELISTED
KalVista Pharmaceuticals
KALV
| $142K | ﹤0.01% |
12,300
-4,300
| -26% | -$54.1K |
|
10741
PUT
James River Group Holdings
JRVR
$191M
| $142K | ﹤0.01% |
22,700
+400
| +2% | +$2.94K |
|
10742
Cato Corp
CATO
$52.8M
| $142K | ﹤0.01% |
28,485
-32,259
| -53% | -$159K |
|
10743
Clarus
CLAR
$145M
| $142K | ﹤0.01% |
+31,518
| New | +$159K |
|
10744
CALL
Goldman Sachs BDC
GSBD
$1.14B
| $142K | ﹤0.01% |
10,300
-82,500
| -89% | -$1.2M |
|
|
DEA
10745
Easterly Government Properties
DEA
$1.17B
| $142K | ﹤0.01% |
+4,168
| New | +$140K |
|
|
GOGL
10746
DELISTED
Golden Ocean Group
GOGL
| $141K | ﹤0.01% |
+10,574
| New | +$131K |
|
|
MRSN
10747
DELISTED
Mersana Therapeutics
MRSN
| $141K | ﹤0.01% |
2,992
-1,362
| -31% | -$60.1K |
|
|
FT
10748
Franklin Universal Trust
FT
$195M
| $141K | ﹤0.01% |
+18,665
| New | +$133K |
|
10749
PUT
Resources Connection
RGP
$146M
| $141K | ﹤0.01% |
14,500
-7,600
| -34% | -$78.5K |
|
10750
PUT
PDS Biotechnology
PDSB
$11.8M
| $141K | ﹤0.01% |
36,800
+20,100
| +120% | +$67.1K |
|
Similar funds
Jeff Yass's Q3 2024 Portfolio in Review
As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
- Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
- Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
- Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
- Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
- Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.
Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.